Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-08-11 12:20Core Viewpoint - The stock of Steady Medical (300888) has shown a slight decline, with significant net outflows from major and retail investors, while the company continues to demonstrate strong financial performance in its recent quarterly report [1][3]. Financial Performance - As of August 11, 2025, Steady Medical's stock closed at 40.5 yuan, down 0.07% with a trading volume of 68,500 hands and a transaction amount of 277 million yuan [1]. - The company reported a main revenue of 2.605 billion yuan for Q1 2025, representing a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also up 36.26% year-on-year [3]. - The company's gross profit margin stands at 48.46%, with a net profit margin of 10.05% [3]. Market Position - Steady Medical has a total market value of 23.584 billion yuan, ranking 4th in the beauty and personal care industry, with a net asset value of 12.146 billion yuan, ranking 1st [3]. - The company has a price-to-earnings ratio (P/E) of 23.72, which is lower than the industry average of 41.33, indicating a potentially undervalued stock [3]. Investor Sentiment - Over the past 90 days, 16 institutions have rated the stock, with 13 buy ratings and 3 hold ratings, suggesting a positive outlook among analysts [4]. - The average target price set by institutions for the stock is 57.38 yuan, indicating potential upside from the current trading price [4]. Capital Flow - On August 11, 2025, the net outflow of major funds was 21.937 million yuan, accounting for 7.93% of the total transaction amount, while retail investors saw a net inflow of 24.797 million yuan, representing 8.96% of the total [1][2].